JQ1 reduces Epstein–Barr virus-associated lymphoproliferative disease in mice without sustained oncogene repression

Click to increase image sizeClick to decrease image size

Acknowledgements

We thank Byron C. Hann and the Preclinical Therapeutics Core at UCSF for help with designing, conducting, and discussing in vivo studies. We are grateful to the UCSF Center for Advanced Technology and the Gladstone Genomics Core for use of shared equipment.

Potential conflict of interest

Disclosure forms provided by the authors are available with the full text of this article online at https://doi.org/10.1080/10428194.2017.1372578.

Additional information

Funding

This project was funded by the UCSF Program for Breakthrough Biomedical Research, funded in part by the Sandler Foundation. Our work was supported by Grant #IRG-97-150-13 from the American Cancer Society.